BBS-1 BACE inhibitor mAb vaccine (Ramot at Tel Aviv University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBBS-1 BACE inhibitor mAb vaccine (Ramot at Tel Aviv University)
Drug Alias NameBBS-1 BACE inhibitor mAb vaccine (NasVax)blocking b-site 1 beta secretase inhibitor monoclonal anibody vaccine (NasVax)BBS-1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionBeta-secretase inhibitors
TargetsBeta-secretase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRamot At Tel Aviv University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A